Medpace has built enduring and sustainable relationships with a global network of research sites because we recognize that our investigators are as vested in the drug development process as we are. And, because sites like working with Medpace, recruitment is streamlined and investigators do better, faster work.
Our research sites rate Medpace highly because of our extensive therapeutic expertise and well-trained Clinical Research Associates (CRAs) who fully understand their indications and protocols. Our CRAs know what investigators value most – effective and open communication, project planning and organization, and good protocol design. Our unique partnering philosophy emphasizes collaboration so we take a consultative approach to examining every protocol from the perspective of the Investigator. Our CRAs are dedicated to an average of only two projects at a time so they can focus on project feasibility analysis, process excellence, monitor training, and ensuring that everyone is continually kept up-to-date.
It’s a matter of how we think about drug development at Medpace – we know what it takes to make projects successful and that’s why we partner with the best research sites around the world.
Investigator Selection
Longstanding relationships with the right investigative sites are integral to the success of every clinical trial. With extensive experience working with thousands of investigators around the world in multiple therapeutic specialties involved in drug and device development, Medpace ensures investigators are selected correctly the first time and global study enrollment proceeds quickly and efficiently.
Our comprehensive selection process requires every site’s Primary Investigator and Coordinator undergo detailed interviews with our therapeutically-focused experts to guarantee proficiency with each study protocol and ensure the site has the patient population and capacity to conduct the study.
We know what it takes to make projects successful and that’s why we’ve developed consistent, longstanding, and positive relationships with a global network of investigative sites. Medpace Clinical Research Associates (CRAs) provide the best organizational representation to our sites – and, as a result, investigators welcome a collegiate relationship and prioritize Medpace studies.
